T1 Level 1235 1249 PCa cell lines
T2 Protein 585 596 lower-grade
T3 Condition 755 759 PSMA
T4 Organism 1481 1489 patients
T5 Gene 387 397 transgenic
T6 Condition 146 149 PCa
T7 Condition 1463 1467 PSMA
T9 Condition 1604 1610 tumors
T10 Condition 700 704 PSMA
T11 Condition 362 366 PSMA
T12 Condition 118 144 metastatic prostate cancer
T13 Condition 448 451 PCa
T14 Biomarker 1180 1183 AKT
T15 Condition 740 746 tumors
T16 Gene 1538 1547 human PCa
T17 Intervention 72 91 prostate epithelium
T19 Condition 1695 1698 PCa
T20 Condition 542 548 tumors
T21 Protein 978 982 MAPK
T22 Condition 755 760 PSMA 
T23 Condition 1217 1222 PSMA 
T24 Biomarker 1342 1348 IGF-1R
T25 Condition 256 259 PCa
T27 Protein 628 641 blood vessels
T28 Condition 564 570 tumors
T29 Condition 332 336 PSMA
T30 Protein 1041 1066 scaffolding protein RACK1
T31 Condition 346 349 PCa
T32 Biomarker 840 846 IGF-1R
T34 Condition 223 228 PSMA 
T35 Condition 1016 1021 PSMA 
T36 Species 377 381 mice
T37 Condition 1587 1591 PSMA
T38 Condition 550 570 PSMA-negative tumors
T39 Condition 63 67 PSMA
T40 Condition 1594 1610  prostate tumors
T41 Gene 1101 1112 β1 integrin
T42 Condition 1235 1238 PCa
T43 Condition 398 401 PCa
T44 Gene 1398 1409 transcripts
T45 Gene 1117 1131 IGF-1R complex
T46 Condition 1016 1020 PSMA
T47 Gene 27 61 prostate-specific membrane antigen
T48 Gene 796 838 type 1 insulin-like growth factor receptor
T50 Condition 718 738 PSMA-positive tumors
T51 Biomarker 1117 1123 IGF-1R
T52 Level 1360 1364 cell
T53 Gene 1758 1769 β1 integrin
T54 Condition 1463 1468 PSMA 
T55 Condition 315 319 PSMA
T56 Biomarker 1751 1757 IGF-1R
T57 Biomarker 899 907 PI3K-AKT
T58 Condition 1217 1221 PSMA
T59 Level 1239 1243 cell
T60 Condition 223 227 PSMA
T61 Condition 550 554 PSMA
T62 Protein 403 408 TRAMP
T64 Condition 1794 1800 tumors
T65 Condition 1587 1592 PSMA 
T66 Species 302 306 mice
T67 Protein 1139 1143 MAPK
T68 Condition 508 512 PSMA
R1 Relation Arg1:T25 Arg2:T66
